Sucampo Pharmaceuticals works to alleviate some of life's more, ahem, uncomfortable conditions. Sucampo works with a group of compounds derived from fatty acids called prostones; it uses prostones in the development of therapies for the treatment of age-related gastrointestinal, respiratory, vascular, and central nervous system disorders. It has two FDA-approved products: AMITIZA, which treats chronic constipation in adults and irritable bowel syndrome in adult women, and Rescula for the treatment of glaucoma and ocular hypertension. Sucampo's pipeline has other candidates in preclinical and early stage clinical development to treat a range of conditions including spinal stenosis and wound healing.